Abstract

Trefoil factor family (TFF) peptides have been shown to effect cell proliferation, apoptosis, migration and invasion of normal cells and various cancer cell lines. In the literature TFF peptides are controversially discussed as tumor suppressors and potential tumor progression factors. In the study presented, we investigated the effect of TFF3 overexpression on growth, viability, migration and tumorigenicity of the human retinoblastoma cell lines Y-79, WERI-Rb1, RBL-13 and RBL-15. As revealed by WST-1 and TUNEL assays as well as DAPI and BrdU cell counts, recombinant human TFF3 significantly lowers retinoblastoma cell viability and increases apoptosis levels. Transient TFF3 overexpression likewise significantly increases RB cell apoptosis. Stable, lentiviral TFF3 overexpression lowers retinoblastoma cell viability, proliferation and growth and significantly increases cell death in retinoblastoma cells. Blockage experiments using a broad-spectrum caspase inhibitor and capase-3 immunocytochemistry revealed the involvement of caspases in general and of caspase-3 in particular in TFF3 induced apoptosis in retinoblastoma cell lines. Soft agarose and in ovo chicken chorioallantoic membrane (CAM) assays revealed that TFF3 overexpression influences anchorage independent growth and significantly decreases the size of tumors forming from retinoblastoma cells. Our study demonstrates that forced TFF3 expression exerts a significant pro-apoptotic, anti-proliferative, and tumor suppressive effect in retinoblastoma cells, setting a starting point for new additive chemotherapeutic approaches in the treatment of retinoblastoma.

Highlights

  • Three trefoil factor family (TFF)-peptides have been characterized in mammals so far (reviewed in refs. [1,2,3,4,5,6]: TFF1—formerly pS2, TFF2—formerly spasmolytic polypeptide, and Trefoil Factor Family Peptide 3 (TFF3)—previously called intestinal trefoil factor (ITF))

  • We demonstrated that the expression of TFF3 in retinoblastoma cell lines is regulated epigenetically [12]

  • We tested the effect of recombinant human TFF3 on Y-79 retinoblastoma cell viability

Read more

Summary

Introduction

Three trefoil factor family (TFF)-peptides have been characterized in mammals so far (reviewed in refs. [1,2,3,4,5,6]: TFF1—formerly pS2, TFF2—formerly spasmolytic polypeptide, and TFF3—previously called intestinal trefoil factor (ITF)). [1,2,3,4,5,6]: TFF1—formerly pS2, TFF2—formerly spasmolytic polypeptide, and TFF3—previously called intestinal trefoil factor (ITF)) They are characterized by a trefoil domain, which has a P-motif, a three-looped structure held together by disulfide bonds [1], whereby TFF2 contains two trefoil domains and TFF1 and TFF3 only contain one trefoil domain [7]. Besides their expression in mucous epithelia, TFF peptides are synthesized in the central nervous system and ocular tissues of rodents and humans [8,9,10]. We demonstrated that the expression of TFF3 in retinoblastoma cell lines is regulated epigenetically [12]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call